×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
VKTX – viking therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
VKTX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/11
11:48 am
vktx
This is why Viking Therapeutics, Inc. (VKTX) is a Strong Buy on Wall Street [Yahoo! Finance]
Low
Report
This is why Viking Therapeutics, Inc. (VKTX) is a Strong Buy on Wall Street [Yahoo! Finance]
12/10
10:38 pm
vktx
Unusual Bullish Options Activity Could Be A Game Changer For Viking Therapeutics (VKTX) [Yahoo! Finance]
Low
Report
Unusual Bullish Options Activity Could Be A Game Changer For Viking Therapeutics (VKTX) [Yahoo! Finance]
12/6
09:07 am
vktx
Viking Therapeutics: Prepping For A Critical 2026 [Seeking Alpha]
Low
Report
Viking Therapeutics: Prepping For A Critical 2026 [Seeking Alpha]
12/1
04:23 am
vktx
Assessing Viking Therapeutics (VKTX) Valuation After Recent Share Price Recovery [Yahoo! Finance]
Medium
Report
Assessing Viking Therapeutics (VKTX) Valuation After Recent Share Price Recovery [Yahoo! Finance]
11/29
01:13 pm
vktx
Viking Therapeutics (VKTX) VANQUISH-1 Trial Completes Early, H.C. Wainwright Retains Buy Rating [Yahoo! Finance]
Medium
Report
Viking Therapeutics (VKTX) VANQUISH-1 Trial Completes Early, H.C. Wainwright Retains Buy Rating [Yahoo! Finance]
11/25
04:05 pm
vktx
Viking Therapeutics to Participate at the Piper Sandler 37th Annual Healthcare Conference
Low
Report
Viking Therapeutics to Participate at the Piper Sandler 37th Annual Healthcare Conference
11/25
05:21 am
vktx
Viking Therapeutics (VKTX) Balances Rising R&D Costs With Clinical Progress: Is the Risk Worth the Potential? [Yahoo! Finance]
Medium
Report
Viking Therapeutics (VKTX) Balances Rising R&D Costs With Clinical Progress: Is the Risk Worth the Potential? [Yahoo! Finance]
11/21
05:31 am
vktx
Viking Therapeutics (NASDAQ:VKTX) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Low
Report
Viking Therapeutics (NASDAQ:VKTX) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Date
Time
Symbol
Company Name
Action
%Chg
10/22/2025
04:05 pm
vktx
viking therapeutics, inc.
MISS
Report
8.0%
viking therapeutics, inc.
4/23/2025
04:05 pm
vktx
viking therapeutics, inc.
MISS
Report
-1.1%
viking therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/5
11:50 am
vktx
Form SCHEDULE 13G/A Viking Therapeutics, Filed by: FMR LLC
Low
Report
Form SCHEDULE 13G/A Viking Therapeutics, Filed by: FMR LLC
10/28
07:51 pm
vktx
Form 4 Viking Therapeutics, For: Oct 27 Filed by: Mancini Marianna
Low
Report
Form 4 Viking Therapeutics, For: Oct 27 Filed by: Mancini Marianna
10/28
07:49 pm
vktx
Form 4 Viking Therapeutics, For: Oct 27 Filed by: Lian Brian
Low
Report
Form 4 Viking Therapeutics, For: Oct 27 Filed by: Lian Brian
10/28
07:49 pm
vktx
Form 4 Viking Therapeutics, For: Oct 27 Filed by: Rowland Charles A Jr
Low
Report
Form 4 Viking Therapeutics, For: Oct 27 Filed by: Rowland Charles A Jr
10/28
07:48 pm
vktx
Form 4 Viking Therapeutics, For: Oct 27 Filed by: ZANTE GREG
Low
Report
Form 4 Viking Therapeutics, For: Oct 27 Filed by: ZANTE GREG
10/28
04:34 pm
vktx
Form 144 Viking Therapeutics, Filed by: ZANTE GREG
Low
Report
Form 144 Viking Therapeutics, Filed by: ZANTE GREG
10/28
04:32 pm
vktx
Form 144 Viking Therapeutics, Filed by: Mancini Marianna
Low
Report
Form 144 Viking Therapeutics, Filed by: Mancini Marianna
10/28
04:28 pm
vktx
Form 144 Viking Therapeutics, Filed by: Lian Brian
Low
Report
Form 144 Viking Therapeutics, Filed by: Lian Brian
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
11/5
Viking Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update
19.0%
3/19 Viking Therapeutics Inc (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at William Blair. 8.1%
5/4 Viking Therapeutics Inc (NASDAQ: VKTX) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 7.2%
12/21 Viking Therapeutics Inc (NASDAQ: VKTX) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. 5.8%
4/3 Form 4 Viking Therapeutics, For: Mar 31 Filed by: MORNEAU MICHAEL 5.4%
11/12 Viking Therapeutics to Participate in Upcoming Investor Conferences 4.9%
10/31 Form 4 Viking Therapeutics, For: Oct 31 Filed by: MORNEAU MICHAEL 4.7%
3/17 Form 8-K Viking Therapeutics, For: Mar 17 3.7%
7/15 Viking Therapeutics Inc (NASDAQ: VKTX) is now covered by analysts at Citigroup Inc. They set an "outperform" rating on the stock. 3.5%
8/6 Viking Therapeutics Inc (VKTX) Q2 2019 Earnings Call Transcript [The Motley Fool] 2.6%
3/19 Viking Therapeutics Inc (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at William Blair. 8.1%
5/4 Viking Therapeutics Inc (NASDAQ: VKTX) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 7.2%
12/21 Viking Therapeutics Inc (NASDAQ: VKTX) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. 5.8%
4/3 Form 4 Viking Therapeutics, For: Mar 31 Filed by: MORNEAU MICHAEL 5.4%
11/12 Viking Therapeutics to Participate in Upcoming Investor Conferences 4.9%
10/31 Form 4 Viking Therapeutics, For: Oct 31 Filed by: MORNEAU MICHAEL 4.7%
3/17 Form 8-K Viking Therapeutics, For: Mar 17 3.7%
7/15 Viking Therapeutics Inc (NASDAQ: VKTX) is now covered by analysts at Citigroup Inc. They set an "outperform" rating on the stock. 3.5%
8/6 Viking Therapeutics Inc (VKTX) Q2 2019 Earnings Call Transcript [The Motley Fool] 2.6%
TOP News Decliners
11/19
Viking launches mid-stage study of VK2809 in NASH; shares up 7% premarket [Seeking Alpha]
-15.5%
3/21 Viking Therapeutics Inc (NASDAQ: VKTX) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -9.0%
1/3 Form 4 Viking Therapeutics, For: Jan 02 Filed by: SINGLETON J MATTHEW -9.0%
2/26 Form 10-K Viking Therapeutics, For: Dec 31 -8.7%
5/28 Viking Therapeutics to Participate in Upcoming Investor Conferences -8.2%
5/1 Viking Therapeutics Inc (NASDAQ: VKTX) is now covered by analysts at BTIG Research. They set a "buy" rating and a $9.00 price target on the stock. -7.6%
8/11 Is Viking Therapeutics a Buy? [The Motley Fool] -7.3%
8/1 Q2/2019 6/30/2019 EPS -0.110 ZacksConsensus -0.090 ActVsEst (0.020) - Miss -6.6%
5/7 3 Top Biotech Stocks to Buy in May [The Motley Fool] -6.2%
4/14 Viking Therapeutics Inc (NASDAQ: VKTX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.8%
3/21 Viking Therapeutics Inc (NASDAQ: VKTX) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -9.0%
1/3 Form 4 Viking Therapeutics, For: Jan 02 Filed by: SINGLETON J MATTHEW -9.0%
2/26 Form 10-K Viking Therapeutics, For: Dec 31 -8.7%
5/28 Viking Therapeutics to Participate in Upcoming Investor Conferences -8.2%
5/1 Viking Therapeutics Inc (NASDAQ: VKTX) is now covered by analysts at BTIG Research. They set a "buy" rating and a $9.00 price target on the stock. -7.6%
8/11 Is Viking Therapeutics a Buy? [The Motley Fool] -7.3%
8/1 Q2/2019 6/30/2019 EPS -0.110 ZacksConsensus -0.090 ActVsEst (0.020) - Miss -6.6%
5/7 3 Top Biotech Stocks to Buy in May [The Motley Fool] -6.2%
4/14 Viking Therapeutics Inc (NASDAQ: VKTX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: